Measuring Success With HUMIRA Video Transcript

[LESLIE]: When my dermatologist said that she felt it was time to try HUMIRA, I had a lot of concerns. Like what can I expect to see from this?

HS is a unique condition and involves a unique measurement of success called HiSCR.

HiSCR is a measurement to determine how well a treatment is working for HS.

When HUMIRA was first introduced to me, I was aware that that was the first FDA-approved medication for HS. FDA approval means it went through clinical trials in patients with moderate to severe HS.

When I first started taking HUMIRA, at my first three month check-in, which I had really great things to report, she had asked me, you know, “How do you feel HUMIRA has affected you? Do you see a decrease in abscesses? At what percentage?”

After three months of being on HUMIRA, half my abscesses and nodules were gone, and I didn't have an increase in the number of abscesses or draining fistulas.

I think today there's definitely an increase in availability and options to be able to educate yourself—help educate your physician, maybe—about HS, the symptoms, and available treatments. It's there and it is being researched and things are being done.


Safety Considerations

HUMIRA can lower your ability to fight infections, including tuberculosis. Serious, sometimes fatal infections and cancers, including lymphoma, have happened; as have blood, liver, and nervous system problems, serious allergic reactions, and new or worsening heart failure. Before treatment, get tested for TB. Tell your doctor if you’ve been to areas where certain fungal infections are common, and if you’ve had TB, hepatitis B, are prone to infections, or have flu-like symptoms or sores. Don’t start HUMIRA if you have an infection. 

Please see additional Important Safety Information on this web page.